Header Logo

Connection

Firdose Nakwa to HIV Protease Inhibitors

Back to Details
This is a "connection" page, showing publications Firdose Nakwa has written about HIV Protease Inhibitors.
Firdose Nakwa
Connection Strength
0,217
HIV Protease Inhibitors
  1. Safety and Pharmacokinetics of Lopinavir/Ritonavir Oral Solution in Preterm and Term Infants Starting Before 3 Months of Age. Pediatr Infect Dis J. 2024 Apr 01; 43(4):355-360.
    View in: PubMed
    Score: 0,217
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.